You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antimalarials

Showing 1 - 25 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Antimalarials in Breastfeeding Ugandan Mother-infant Pairs

Not yet recruiting
  • Malaria,Falciparum
  • (no location specified)
Jan 4, 2023

Toxicity, Drug, Maculopathy Trial in Paris (spectral domain optical coherence tomography C-scan and multifocal

Completed
  • Toxicity, Drug
  • Maculopathy
  • spectral domain optical coherence tomography C-scan and multifocal electroretinogram
  • Paris, France
    Fondation Ophtalmique Adolphe de Rothschild
Dec 17, 2021

Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis Trial in Edmonton (Hydroxychloroquine/Chloroquine)

Active, not recruiting
  • Covid-19 Infection
  • +3 more
  • Hydroxychloroquine/Chloroquine
  • Edmonton, Alberta, Canada
    University of Alberta
Jul 19, 2022

Malaria Fever, Plasmodium Falciparum Malaria, Uncomplicated Malaria Trial in Ibadan (Antimalarials, pyronaridine-artesunate,

Completed
  • Malaria Fever
  • +2 more
  • Antimalarials, pyronaridine-artesunate
  • Antimalarials, Artemether + Lumefantrine
  • Ibadan, Oyo, Nigeria
    Ikeoluwapo O Ajayi
Mar 29, 2022

Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM

Recruiting
  • Infections
  • +11 more
  • MMV367
  • P. falciparum IBSM infection
  • Brisbane, Queensland, Australia
  • +1 more
Jul 30, 2023

Plasmodium Falciparum Malaria Trial in Mae Sot (Ultrasensitive Rapid Diagnostic Test (URDT), Antimalarials)

Completed
  • Plasmodium Falciparum Malaria
  • Ultrasensitive Rapid Diagnostic Test (URDT)
  • Antimalarials
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit
Feb 14, 2022

Systemic Lupus Erythematosus (SLE) Trial in United States (Anifrolumab, Standard of Care)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • New Haven, Connecticut
  • +4 more
Nov 18, 2021

Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)

Enrolling by invitation
  • Hydroxychloroquine
  • +3 more
  • Hydroxychloroquine Sulfate
  • Bromhexine 8 MG
  • Mexico City, Cdmx, Mexico
    National Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
Jun 26, 2021

Uncomplicated Falciparum Malaria Trial in Ndola (Artemether-lumefantrine, Dihydroartemisinin-piperaquine)

Active, not recruiting
  • Uncomplicated Falciparum Malaria
  • Ndola, Copperbelt, Zambia
    Tropical Diseases Research Centre
Aug 7, 2020

Fever, Malaria Trial in Eldoret (Malaria RDT & conditional voucher for ACT from retail sector)

Completed
Has Results
  • Fever
  • Malaria
  • Malaria RDT & conditional voucher for ACT from retail sector
  • Eldoret, Kenya
    Moi University
Oct 8, 2019

Antiphospholipid Syndrome Trial in Athens (Hydroxychloroquine)

Completed
  • Antiphospholipid Syndrome
  • Athens, Attiki, Greece
    Laikon General Hospital
Nov 3, 2019

Lupus Erythematosus, Systemic Trial in Beijing (Belimumab, Standard of care)

Completed
  • Lupus Erythematosus, Systemic
  • Belimumab
  • Standard of care
  • Beijing, Dongcheng, China
    Peking Union Medical College hospital
Jul 5, 2022

Lupus Erythematosus, Systemic Trial in China (Telitacicept, Standard of Care)

Recruiting
  • Lupus Erythematosus, Systemic
  • Beijing, Beijing, China
  • +19 more
Jun 1, 2023

MiMBa Pregnancy Registry

Recruiting
  • Malaria in Pregnancy
  • +2 more
    • Kisumu, Kenya
      Kenya Medical Research Institute
    Mar 30, 2021

    Lupus Nephritis Trial in Philippines, Taiwan (ANX009)

    Recruiting
    • Lupus Nephritis
    • ANX009
    • Angeles City, Philippines
    • +6 more
    Mar 10, 2023

    Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2

    Completed
    • Malaria
      • Bissau, Bissau Codex, Guinea-Bissau
        Bandim Health Project
      May 25, 2021

      Malaria, Febrile Illness Trial in Lagos (Testing incentive, Conditional artemisinin combination therapy subsidy)

      Recruiting
      • Malaria
      • Febrile Illness
      • Testing incentive
      • Conditional artemisinin combination therapy subsidy
      • Lagos, Nigeria
        Clinton Health Access Initiative
      Feb 4, 2022

      l Antimalarial Drugs, Malaria Vaccines, and Controlled Human

      Recruiting
      • Malaria
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Malaria in Pregnancy Trial in Kinshasa (Sulfadoxine pyrimethamine, Pyramax)

        Active, not recruiting
        • Malaria in Pregnancy
        • Kinshasa, Congo, The Democratic Republic of the
          Maternité Esengo
        Jul 7, 2022

        Systemic Lupus Erythematosus Trial in Yantai (Placebo plus standard therapy, RC18 160 mg plus standard therapy)

        Active, not recruiting
        • Systemic Lupus Erythematosus
        • Placebo plus standard therapy
        • RC18 160 mg plus standard therapy
        • Yantai, Shandong, China
          Remegen，ltd.
        Jan 7, 2022

        Systemic Lupus Erythematosus, Lupus Nephritis Trial in Barcelona (YTB323)

        Recruiting
        • Systemic Lupus Erythematosus
        • Lupus Nephritis
        • Barcelona, Catalunya, Spain
          Novartis Investigative Site
        Mar 22, 2023

        Malaria, Falciparum Trial in Cambodia, Vietnam (ACT, TACT)

        Completed
        Has Results
        • Malaria, Falciparum
        • Siem Pang, Stung Treng, Cambodia
        • +3 more
        Mar 17, 2022

        Practice of Treat-to-target on Pediatric Systemic Lupus

        Not yet recruiting
        • Systemic Lupus Erythematosus
          • (no location specified)
          Jun 19, 2021

          Discoid Lupus Erythematosus Trial in Cairo (Nicotinamide Topical)

          Completed
          • Discoid Lupus Erythematosus
          • Nicotinamide Topical
          • Cairo, Egypt
            AL-Azhar University Hospital
          Oct 22, 2022

          Discoid Lupus Erythematosus, Systemic Lupus Erythematosus Trial in Boston (Tofacitinib citrate)

          Terminated
          • Discoid Lupus Erythematosus
          • Systemic Lupus Erythematosus
          • Tofacitinib citrate
          • Boston, Massachusetts
            Tufts Medical Center
          Jan 6, 2022